Aging-related gene signature regulated by Nlrp3 predicts glioma progression

American Journal of Cancer Research

Volumn 5, Issue 1, 2015, Pages 442-449

  Li, Lianling ^a,b   Liu, Yuguang ^a,b  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Aging; Gene signature; Glioma; Nlrp3; Radiotherapy

Indexed keywords

CRYOPYRIN; INFLAMMASOME; SHORT HAIRPIN RNA;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; GENE EXPRESSION; GLIOBLASTOMA; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PREDICTION; PROTEIN EXPRESSION; RADIOSENSITIVITY; SENESCENCE; TUMOR XENOGRAFT;

EID: 84987879480     PISSN: None     EISSN: 21566976     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, Hau P, Brandes AA, Gijtenbeek J, Marosi C, Vecht CJ, Mokhtari K, Wesseling P, Villa S, Eisenhauer E, Gorlia T, Weller M, Lacombe D, Cairncross JG, Mirimanoff RO; European Organisation for Research and Treatment of Cancer Brain Tumour and Radiation Oncology Groups and National Cancer Institute of Canada Clinical Trials Group. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 2009; 10: 459-466.
2. Curran WJ Jr, Scott CB, Horton J, Nelson JS, Weinstein AS, Fischbach AJ, Chang CH, Rotman M, Asbell SO and Krisch RE. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 1993; 85: 704-710.
3. Porter KR, McCarthy BJ, Freels S, Kim Y and Davis FG. Prevalence estimates for primary brain tumors in the United States by age, gender, behavior, and histology. Neuro Oncol 2010; 12: 520-527.
4. Ohgaki H, Dessen P, Jourde B, Horstmann S, Nishikawa T, Di Patre PL, Burkhard C, Schüler D, Probst-Hensch NM, Maiorka PC, Baeza N, Pisani P, Yonekawa Y, Yasargil MG, Lütolf UM and Kleihues P. Genetic pathways to glioblastoma: a population-based study. Cancer Res 2004; 64: 6892-6899.
5. Wen H, Miao EA and Ting JP. Mechanisms of NOD-like receptor-associated inflammasome activation. Immunity 2013; 39: 432-41.
6. Walsh JG, Muruve DA and Power C. Inflammasomes in the CNS. Nat Rev Neurosci 2014; 15: 84-97.
7. Latz E, Xiao TS and Stutz A. Activation and regulation of the inflammasomes. Nat Rev Immunol 2013; 13: 397-411.
8. Terlizzi M, Casolaro V, Pinto A and Sorrentino R. Inflammasome: cancer's friend or foe? Pharmacol Ther 2014; 143: 24-33.
9. Chen LC, Wang LJ, Tsang NM, Ojcius DM, Chen CC, Ouyang CN, Hsueh C, Liang Y, Chang KP, Chen CC and Chang YS. Tumor inflammasome-derived IL-1ß recruits neutrophils and improves local recurrence-free survival in EBV-induced nasopharyngeal carcinoma. EMBO Mol Med 2012; 4: 1276-93.
10. Chow MT, Sceneay J, Paget C, Wong CS, Duret H, Tschopp J, Möller A and Smyth MJ. NLRP3 suppresses NK cell-mediated responses to carcinogen-induced tumors and metastases. Cancer Res 2012; 72: 5721-32.
11. Youm YH, Grant RW, McCabe LR, Albarado DC, Nguyen KY, Ravussin A, Pistell P, Newman S, Carter R, Laque A, Münzberg H, Rosen CJ, Ingram DK, Salbaum JM and Dixit VD. Canonical Nlrp3 inflammasome links systemic low-grade inflammation to functional decline in aging. Cell Metab 2013; 18: 519-32.
12. Lee JJ, Kim BC, Park MJ, Lee YS, Kim YN, Lee BL and Lee JS. PTEN status switches cell fate between premature senescence and apoptosis in glioma exposed to ionizing radiation. Cell Death Differ 2011; 18: 666-77.
13. Nam HY, Han MW, Chang HW, Lee YS, Lee M, Lee HJ, Lee BW, Lee HJ, Lee KE, Jung MK, Jeon H, Choi SH, Park NH, Kim SY and Kim SW. Radioresistant cancer cells can be conditioned to enter senescence by mTOR inhibition. Cancer Res 2013; 73: 4267-77.
14. Gravendeel LA, Kouwenhoven MC, Gevaert O, de Rooi JJ, Stubbs AP, Duijm JE, Daemen A, Bleeker FE, Bralten LB, Kloosterhof NK, De Moor B, Eilers PH, van der Spek PJ, Kros JM, Sillevis Smitt PA, van den Bent MJ and French PJ. Intrinsic gene expression profi les of gliomas are a better predictor of survival than histology. Cancer Res 2009; 69: 9065-72.
15. Cancer Genome Atlas Research Network. Comprehensive genomic characterization defi nes human glioblastoma genes and core pathways. Nature 2008; 455: 1061-1068.
16. Blalock EM, Chen KC, Sharrow K, Herman JP, Porter NM, Foster TC and Landfi eld PW. Gene microarrays in hippocampal aging: statistical profi ling identifi es novel processes correlated with cognitive impairment. J Neurosci 2003; 23: 3807-19.
17. Rowe WB, Blalock EM, Chen KC, Kadish I, Wang D, Barrett JE, Thibault O, Porter NM, Rose GM and Landfi eld PW. Hippocampal expression analyses reveal selective association of immediate-early, neuroenergetic, and myelinogenic pathways with cognitive impairment in aged rats. J Neurosci 2007; 27: 3098-3110.
18. Kadish I, Thibault O, Blalock EM, Chen KC, Gant JC, Porter NM and Landfi eld PW. Hippocampal and cognitive aging across the lifespan: a bioenergetic shift precedes and increased cholesterol traffi cking parallels memory impairment. J Neurosci 2009; 29: 1805-16.
19. Blalock EM, Grondin R, Chen KC, Thibault O, Thibault V, Pandya JD, Dowling A, Zhang Z, Sullivan P, Porter NM and Landfi eld PW. Aging-related gene expression in hippocampus proper compared with dentate gyrus is selectively associated with metabolic syndrome variables in rhesus monkeys. J Neurosci 2010; 30: 6058-71.
20. Advani SJ, Buckel L, Chen NG, Scanderbeg DJ, Geissinger U, Zhang Q, Yu YA, Aguilar RJ, Mundt AJ and Szalay AA. Preferential replication of systemically delivered oncolyticvaccinia virus in focally irradiated glioma xenografts. Clin Cancer Res 2012; 18: 2579-90.
21. Debacq-Chainiaux F, Erusalimsky JD, Campisi J and Toussaint O. Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo. Nat Protoc 2009; 4: 1798-806.
22. Meng J, Li P, Zhang Q, Yang Z and Fu S. A radiosensitivity gene signature in predicting glioma prognostic via EMT pathway. Oncotarget 2014; 5: 4683-4693.
23. Pal S, Bi Y, Macyszyn L, Showe LC, O'Rourke DM and Davuluri RV. Isoform-level gene signature improves prognostic stratifi cation and accurately classifi es glioblastoma subtypes. Nucleic Acids Res 2014; 42: e64.
24. Bhat KP, Balasubramaniyan V, Vaillant B, Ezhilarasan R, Hummelink K, Hollingsworth F, Wani K, Heathcock L, James JD, Goodman LD, Conroy S, Long L, Lelic N, Wang S, Gumin J, Raj D, Kodama Y, Raghunathan A, Olar A, Joshi K, Pelloski CE, Heimberger A, Kim SH, Cahill DP, Rao G, Den Dunnen WF, Boddeke HW, Phillips HS, Nakano I, Lang FF, Colman H, Sulman EP and Aldape K. Mesenchymal differentiation mediated by NF-κB promotes radiation resistance in glioblastoma. Cancer Cell 2013; 24: 331-46.
25. Holdhoff M and Chamberlain MC. Controversies in the treatment of elderly patients with newly diagnosed glioblastoma. J Natl Compr Canc Netw 2013; 11: 1165-1172.
26. Fiorentino A, De Bonis P, Chiesa S, Balducci M and Fusco V. Elderly patients with glioblastoma: the treatment challenge. Expert Rev Neurother 2013; 13: 1099-105.
27. Huang YH, Yang PM, Chuah QY, Lee YJ, Hsieh YF, Peng CW and Chiu SJ. Autophagy promotes radiation-induced senescence but inhibits bystander effects in human breast cancer cells. Autophagy 2014; 10: 1212-1228.
28. Gordon RR and Nelson PS. Cellular senescence and cancer chemotherapy resistance. Drug Resist Updat 2012; 15: 123-131.
29. Salama R, Sadaie M, Hoare M and Narita M. Cellular senescence and its effector programs. Genes Dev 2014; 28: 99-114.
30. Pérez-Mancera PA, Young AR and Narita M. Inside and out: the activities of senescence in cancer. Nat Rev Cancer 2014; 14: 547-58.
31. Cahu J, Bustany S and Sola B. Senescence-associated secretory phenotype favors the emergence of cancer stem-like cells. Cell Death Dis 2012; 3: e446.